EUR/USD 1.18038
-0.024%
Gold 4945.75
-0.401%
Oil 63.952
-0.436%
USD/JPY 156.864
-0.006%
GBP/USD 1.36479
-0.031%
GBP/JPY 214.091
-0.015%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On February 5th, shares of Qualcomm and Arm fell sharply after releasing their quarterly earnings reports, primarily due to market concerns that a shortage of memory chips would stifle growth in the electronics industry. In after-hours trading Wednesday evening, both companies shares dropped by more than 8%. Qualcomm, the largest manufacturer of smartphone processors, and Arm, which relies heavily on patent royalties from the mobile phone industry, both companies management teams signaled that supply constraints on memory chips would limit mobile phone production. The unprecedented expansion of artificial intelligence infrastructure is currently causing a shortage of memory chips, as these components help computers manage data. Manufacturers are currently focusing their production capacity on supplying AI data centers, resulting in insufficient production capacity for mobile phone components. This means fewer products will ultimately reach consumers, and at higher prices. Other companies have also sounded the alarm about a memory chip shortage. MediaTek stated in a conference call this week that the situation is "evolving." Intels CEO stated that the shortage could last for years, and suppliers have told him that the situation will not improve until 2028.Boeing (BA.N) plans to move engineering work on its 787 aircraft to South Carolina, and the Boeing engineers union is urging the company to provide more information about the move.February 5th - Everest Medicines (01952.HK), a Hong Kong-listed innovative pharmaceutical company, announced that it has signed an exclusive commercialization licensing agreement with McCormick, acquiring exclusive commercialization rights for its first-in-class dual-target peptide drug MT1013 in China and the Asia-Pacific region (excluding Japan). According to the agreement, Everest Medicines will pay McCormick an upfront payment of RMB 200 million, plus potential regulatory and commercial milestone payments of up to RMB 1.04 billion. Phase III clinical trials in China are currently underway, and related clinical development costs will be borne by McCormick.A chart summarizing the overnight price movements of international spot platinum and palladium.The Japanese government announced that TSMC (TSM.N) CEO C.C. Wei will visit the office of Japanese Prime Minister Sanae Takaichi at 02:00 GMT (10:00 Beijing time).

S&P 500 Price Forecast – 3700 Continues to Hold as Support

Skylar Shaw

Jun 23, 2022 14:55

微信截图_20220623144903.png


After initially tumbling into the 3700 support level throughout the trading day, the S&P 500 has made a big rebound. 

S&P 500 Technical Analysis

After first dropping below the 3700 level during the trading session on Wednesday, the S&P 500 has seen a wild journey. Since the 3700 level has been significant for a few weeks, it is probable that sellers will now make it their goal. 3600 and 3500 are the next targets if we can drop below the most recent low. What we are currently witnessing is a small-scale bear market rebound, which does make some sense given the extreme selling pressure that we had previously witnessed.


If we do move higher from here, 4000 should be a resistance level that will be difficult to surpass unless there is a fundamental shift in the news. In the end, I believe we have a position where breaking down makes more sense, but we could be in for a setup where we "fade the rallies." Since there is nothing positive in the economic pipeline right now and many earnings predictions will need to be revised at this point, I do not enjoy investing in the stock market right now. A brief recovery rally does, however, make a lot of sense because markets do not continuously decline.


I see this as a chance to go short once more, but if we were to breach the 4200 level, you would need to be persuaded that the true brand has changed. I'm not currently concerned about the move because it costs 400 points. In the end, a recession is inevitable, and the market is now beginning to reflect that.

Suggestion